Results 51 to 60 of about 633,561 (92)

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial. [PDF]

ESMO Open
Seguí E, Brasó-Maristany F, Pascual T, Sanfeliu E, Victoria I, Saura C, Hierro C, López-González A, Izarzugaza Y, Ciruelos E, Gavilá J, Racca F, Cejalvo JM, Amillano K, Paz-Ares L, Juan M, Felip E, Garralda E, González B, Arance A, Martín-Liberal J, Conte B, Walbaum B, Indacochea A, Castillo O, Blasco P, Pardo F, Aguirre Á, Sirenko V, González X, Galván P, Vivancos A, Ferrero-Cafiero JM, Mulero-Sánchez A, Salvador F, Villacampa G, Mesía R, Cervantes A, Prat A, Tabernero J.   +39 more
europepmc   +1 more source

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. [PDF]

Br J Cancer, 2012
Gallardo A, Lerma E, Escuin D, Tibau A, Muñoz J, Ojeda B, Barnadas A, Adrover E, Sánchez-Tejada L, Giner D, Ortiz-Martínez F, Peiró G.   +11 more
europepmc   +1 more source

[Fernando Oreste Nannetti's mural at the Volterra Psychiatric Hospital, Italy: iconographic analysis]. [PDF]

Hist Cienc Saude Manguinhos
Arrogante PT.
europepmc   +1 more source

Slug Is Increased in Vascular Remodeling and Induces a Smooth Muscle Cell Proliferative Phenotype. [PDF]

PLoS One, 2016
Coll-Bonfill N, Peinado VI, Pisano MV, Párrizas M, Blanco I, Evers M, Engelmann JC, García-Lucio J, Tura-Ceide O, Meister G, Barberà JA, Musri MM.   +11 more
europepmc   +1 more source

NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts. [PDF]

Signal Transduct Target Ther
Amengual J, Gonzalez-Sanchez E, Yáñez-Bartolome M, Sererols-Viñas L, Ravichandra A, Guiton C, Fuste NP, Alay A, Hijazo-Pechero S, Martín-Mur B, Gut M, Esteve-Codina A, Cantos-Cortes A, Espinosa-Sotelo R, Ramos E, Serrano T, Calvo M, Laquente B, Ferrer J, Pons G, Mendez-Lucas A, Dooley S, Ilyas SI, Vallette M, Aoudjehane L, Lequoy M, Fouassier L, Coulouarn C, Affò S, Scheiter A, Calvisi DF, Tian TV, Fabregat I, Vaquero J.   +33 more
europepmc   +1 more source

Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine). [PDF]

PLoS One, 2017
Muñoz-Esquerre M, Aliagas E, López-Sánchez M, Escobar I, Huertas D, Penín R, Dorca J, Santos S.   +7 more
europepmc   +1 more source

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer. [PDF]

Br J Cancer, 2017
Codony-Servat J, Cuatrecasas M, Asensio E, Montironi C, Martínez-Cardús A, Marín-Aguilera M, Horndler C, Martínez-Balibrea E, Rubini M, Jares P, Reig O, Victoria I, Gaba L, Martín-Richard M, Alonso V, Escudero P, Fernández-Martos C, Feliu J, Méndez JC, Méndez M, Gallego J, Salud A, Rojo F, Castells A, Prat A, Rosell R, García-Albéniz X, Camps J, Maurel J.   +28 more
europepmc   +1 more source

TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion. [PDF]

Aging (Albany NY), 2017
Kandhaya-Pillai R, Miro-Mur F, Alijotas-Reig J, Tchkonia T, Kirkland JL, Schwartz S.   +5 more
europepmc   +1 more source

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours. [PDF]

Br J Cancer, 2019
Serrano C, Mariño-Enríquez A, Tao DL, Ketzer J, Eilers G, Zhu M, Yu C, Mannan AM, Rubin BP, Demetri GD, Raut CP, Presnell A, McKinley A, Heinrich MC, Czaplinski JT, Sicinska E, Bauer S, George S, Fletcher JA.   +18 more
europepmc   +1 more source

Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. [PDF]

Br J Cancer, 2014
Peiró G, Ortiz-Martínez F, Gallardo A, Pérez-Balaguer A, Sánchez-Payá J, Ponce JJ, Tibau A, López-Vilaro L, Escuin D, Adrover E, Barnadas A, Lerma E.   +11 more
europepmc   +1 more source